Cercare Medical, an Aarhus, Denmark-based leader in perfusion software for stroke and neurodegenerative diseases, raised €7.4m (£6.17m GBP / $7.77m USD) in its latest funding round.
The round was led by UK-based West Hill Capital.
This funding will be used to expand operations in key markets, with a focus on the United States, the UK, and selected European countries.
Led by Jeppe Øvlesen, Chairman, and Kim Mouridsen, CEO, Cercare Medical has developed a software (CMN) platform that provides advanced perfusion maps for both CT and MRI imaging, equipping clinicians with a comprehensive tool to assess brain tissue pathologies.
Cercare Medical is a provider of advanced perfusion imaging solutions. With fully automated and multi-vendor compatible software for CT and MRI perfusion imaging post-processing, they are committed to delivering technology that enhances patient care and advances medical diagnostics across various neurological conditions, including Stroke, Oncology, Alzheimer’s, Dementia, and COVID-19. Its proprietary biomarkers allow for better, more precise imaging maps, improving decision-making in critical care and enhancing neuroimaging.
Over recent years, the company has achieved yearly triple-digit growth and has been adopted by prominent stroke and oncology facilities in more than 23 countries. As part of its expansion strategy, Cercare Medical is deepening its collaborations with key industry partners, including Microsoft, Siemens, Blackford, Aidoc, SECTRA, TeraRecon, and Viz.AI.
FinSMEs
05/03/2025